NCT07927192: Medical Nitrous Oxide Combined With Personalized Traumatic Script Exposure for the Treatment of Post-Traumatic Stress Disorder
- State
- Not started
- Phase
- Phase 3
- People
- 96 planned
- Started
- Jan 2027
- Primary completion
- Sep 2027
- Arms
- MEOPA + Personalized Traumatic Script Exposure
- Results
- None posted
- 10 Nov 2026: Trial registered